p21(Waf1/Cip1) Inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption

Molecular and Cellular Biology

Volumn 19, Issue 1, 1999, Pages 205-215

  Stewart, Zoe A ^a,b   Leach, Steven D ^a,b   Pietenpol, Jennifer A ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; NOCODAZOLE; PROTEIN P21;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; DNA SYNTHESIS; ENZYME ASSAY; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN CELL; MITOSIS; MITOSIS SPINDLE; PRIORITY JOURNAL;

EID: 0032952584     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.1.205     Document Type: Article

References (63)

1. Arellano, M., and S. Moreno. 1997. Regulation of CDK/cyclin complexes during the cell cycle. Int. J. Biochem. Cell Biol. 29:559-573.
2. Chellappan, S. P., S. Hiebert, M. Mudryj, J. M. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053-1061.
3. Chen, J., P. K. Jackson, M. W. Kirschner, and A. Dutta. 1995. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature 374:386-388.
4. Chen, J., T. Willingham, M. Shuford, D. Brace, E. Rushing, V. Smith, and P. D. Nisen. 1996. Effects of ectopic overexpression of p21WAF1/CIP1 on aneuploidy and the malignant phenotype of human brain tumor cells. Oncogene 13:1395-1403.
5. Cohen-Fix, O., and D. Koshland. 1997. The metaphase-to-ananphase transition: avoiding a mid-life crisis. Curr. Opin. Cell Biol. 9:800-806.
6. Cross, S. M., C. A. Sanchez, C. A. Morgan, M. K. Schimke, S. Ramel, R. L. Idzerda, W. H. Raskind, and B. J. Reid. 1995. A p53-dependent mouse spindle checkpoint. Science 267:1353-1356.
7. Di Leonardo, A., S. H. Khan, S. P. Linke, V. Greco, G. Seidita, and G. M. Wahl. 1997. DNA rereplication in the presence of mitotic spindle inhibitors in human and mouse fibroblasts lacking either p53 or pRb function. Cancer Res. 57:1013-1019.
8. 1-S phase protein kinase. Science 257:1958-1961.
9. 1 arrest and apoptosis. Cancer Res. 54:1169-1174.
10. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAFI. a potential mediator of p53 tumor suppression. Cell 75:817-825.
11. Gorbsky, G. J. 1997. Cell cycle checkpoints: arresting progress in mitosis. Bioessays 19:193-197.
12. Gu, Y., C. W. Turck, and D. O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707-710.
13. 5INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371:257-261.
14. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge, 1993. The p21 Cdk-interacting protein Cipl is a potent inhibitor of Gl cyclin-dependent kinases. Cell 75:805-816.
15. Hartwell, L. 1992. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543-546.
16. Hartwell, L. H., and M. B. Kastan. 1994. Cell cycle control and cancer. Science 266:1821-1828.
17. Hartwell, L. H., and T. A. Weinert. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science 246:629-634.
18. Helin, K., and E. Harlow. 1993. The retinoblastoma protein as a tntnscriptional repressor. Trends Cell Biol. 3:43-46.
19. Hiebert, S. W., S. Chellappan, J. M. Horowitz, and J. R. Nevins. 1992. The interaction of RB with E2F coincides with inhibition of the transcriptional activity of E2F. Genes Dev. 6:177-185.
20. Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
21. Hirai, H., M. F. Roussel, J.Y. Kato, R. A. Ashmun, and C. J. Sherr. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol. 15:2672-2681.
22. Hoyt, M. A., L. Totis, and B. T. Roberts. 1991. S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 66:507-517.
23. Hunter, T., and J. Pines. 1994. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582.
24. Kamb, A., N. A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshman, S. V. Tavtigian, E. Stockert, R. S. Day, III. B. E. Johnson, and M. H. Skolnick. 1994. A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440.
25. 1 arrest. Cancer Res. 58:396-401.
26. Koff, A., A. Giordano, D. Desai, K. Yamashita, J. W. Harper, S. Elledge, T. Nishimoto, D. O. Morgan, B. R. Franza, and J. M. Roberts. 1992. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257:1689-1694.
27. Lanni, J. S., and T. S. Jacks. 1998. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell Biol. 18:1055-1064.
28. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 9:639-649.
29. Li, Y., C. W. Jenkins, M. A. Nichols, and Y. Xiong. 1994. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 9:2261-2268.
30. C1p1. Nature 375:159-161.
31. CIPI Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650-662.
32. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077-2086.
33. Minn, A. J., L. H. Boise, and C. B. Thompson. 1996. Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev. 10:2621-2631.
34. Mitsudomi, T., S. M. Steinberg, M. M. Nau, D. Carbone, D. D'Amico, S. Bodner, H. K. Oie, R. I. Linnoila, J. L. Mulshine, J. D. Minna, and A. F. Gazdar. 1992. p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171-180.
35. cdc2 protein kinase during mitosis. Cell 58:361-372.
36. Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131-134.
37. Myöhänen, S. K., S. B. Baylin, and J. G. Herman. 1998. Hypermethylation can selectively silence individual p16ink4.4 alleles in neoplasia. Cancer Res. 58:591-593.
38. 2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol. Cell. Biol. 18:629-643.
39. Nurse, P. 1990. Universal control mechanism regulating onset of M-phase. Nature 344:503-508.
40. 1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
41. Paulovich, A. G., D. P. Toczyski, and L. H. Hartwell. 1997. When checkpnints fail. Cell 88:315-321.
42. Pellegata, N. S., R. J. Antoniono, J. L. Redpath, and E. J. Stanbridge. 1996. DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc. Natl. Acad. Sci. USA 93:15209-15214.
43. cdc2. Cell 58:833-846.
44. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22.
45. Polyak, K., M.-H. Lee, H. Erdjument-Bromage, A. Koff, J. M. Roberts, P. Tempst, and J. Massague. 1994. Cloning of p27Kipl, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:54-66.
46. Reed, S. I. 1992. The role of p34 kinases in the G1 to S-phase transition. Annu. Rev. Cell Biol. 8:529-561.
47. Schwarz, J. K., S. H. Devoto, E. J. Smith, S. P. Chellappan, L. Jakoi, and J. R. Nevins. 1993. Interactions of the p107 and Rh proteins with E2F during the cell proliferation response. EMBO J. 12:1013-1020.
48. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell-cycle control causing specific inhibition of cyelin D/CDK4. Nature 366: 704-707.
49. Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
50. 1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
51. MO15, EMBO J. 12:3133-3142.
52. Sorger, P. K., M. Dobles, R. Tournebize, and A. A. Hyman. 1997 Coupling cell division and cell death to microtubule dynamics. Curr. Opin. Cell Biol. 9:807-814.
53. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
54. Tsai, L., E. Lees, B. Faha, E. Harlow, and K. Riabowol. 1993. The cdk2 kinase is required for the G1-to-S-phase transition in mammalian cells. Oncogene 8:1593-1602.
55. Waga, S., G. J. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578.
56. Waldmann, T., K. W. Kinzler, and B. Vogelstein. 1995. p21 is necessary for the p53-medialed G1 arrest in human cancer cells. Cancer Res. 55:5187-5195.
57. Wang, J. Y. 1997. Retinoblastoma protein in growth suppression and death protection. Curr. Opin. Genet. Dev. 7:39-45.
58. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
59. Xiong, Y. 1996. Why are there so many CDK inhibitors? Biochim. Biophys. Acta Rev. Cancer 1288:1-5.
60. Xiong, V., G. J. Hannon, H. Zhang, U. Casso, R. Kobayashi, and O. Beach. 1993. p21 is a universal inhibitor of cyelin kinases. Nature 366:701-704.
61. Xiong, Y., H. Zhang, and D. Beach. 1992. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505-514.
62. Xiong, Y., H. Zhang, and D. Beach. 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7:1572-1583.
63. Zhang, H., Y. Xiong, and D. Beach. 1993. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell 4:897-906.